Approval · Notice of Compliance 3617 · 2003
THIOTEPA: Notice of Compliance 3617
Issued April 23, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3617
- Date
- April 23, 2003
- Company
- Wyeth CanadaSt. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Cytotoxic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| THIOTEPA | 02174391 | Cancelled Post Market |
Medicinal ingredients
- THIOTEPA 15 MG per VIAL